Source comparison
Research Compounds vs. Approved Medications: A Necessary Comparison
To put this into perspective, our team put together a table to illustrate the monumental gap between a research peptide and a medication deemed acceptable for use during pregnancy. It's a stark contrast. Human Clinical Trials None in pregnant populations. Exte
This comparison does not assign a generated winner or score.
- To put this into perspective, our team put together a table to illustrate the monumental gap between a research peptide and a medication deemed acceptable for use during pregnancy. It's a stark contrast.
- Human Clinical Trials
- None in pregnant populations.
- Extensive, multi-phase trials to establish safety and efficacy.
- Safety Data
- A complete absence of data. Risks are entirely unknown.
- Well-documented safety profiles, often with decades of data.
- Regulatory Oversight
- Not approved for human consumption; sold for research purposes only.
- Rigorously reviewed and approved by the FDA and other global bodies.
- Risk Profile
- Theoretical risks are severe, including potential for birth defects.
- Known risks are categorized (e.g., Pregnancy Categories) and quantified.
- Professional Guidance
- No doctor would ever recommend its use during pregnancy.
- Prescribed by a qualified physician after a risk-benefit analysis.
- Source & Purity
- Varies wildly by supplier; our focus at Real Peptides is on purity for labs.
- Manufactured under strict Good Manufacturing Practices (GMP).
- This isn't just about paperwork. It's about a fundamental difference in purpose and proven safety. The compounds we offer, from our BPC-157 Capsules to our more complex stacks, are intended for one thing: controlled, in-vitro or pre-clinical research. They allow scientists to explore biological pathways in a lab, not to self-experiment during the most delicate phase of human life.